You need to enable JavaScript in order to use the AI chatbot tool powered by ChatBot

Resources

Generation of Historical Control Database, Acceptance and Interpretation Criteria in a Comparative T4-Glucuronidation Assay Using Primary Human and Rat Hepatocyte (TruVivo®) for Regulatory Acceptance

Ahtasham Raza1, Stephanie Kellum1, Justin Brown1, Suhair Al Janabi1, Lauren Kent2, Marco Corvaro3, Jinlan Dong1, Jessica LaRocca4, Edward LeCluyse5, Raja Settivari1 and Shadia M. I. Catalano1

1Corteva Agriscience (DE, USA), 2Corteva Agriscience (Oxford, U.K), 3Corteva Agriscience (Cremona, Italy), 4Corteva Agriscience (IN, USA), 5LifeNet Health LifeSciences (NC, USA).

 

Introduction:

Evaluating the human relevance of liver-mediated thyroid hormone disruption remains a significant challenge within the European Union (EU) regulatory framework. Currently, no in vitro methodologies exist with established guidelines, acceptance criteria, or interpretation frameworks that can quantitatively assess such disruption across species. This gap hinders both applicants and regulators in determining the human relevance of chemically induced thyroid toxicity. New Approach Methodologies (NAMs) offer a promising solution by enabling direct comparisons between human and rat hepatic responses. Among these, the comparative in vitro hepatic enzyme assay is specifically highlighted in the ECHA-EFSA guidance on endocrine disruptors. However, its development and implementation have proven technically complex and difficult to standardize. This study contributes to the advancement of NAMs by utilizing TruVivo®, a tri-culture hepatic model composed of hepatocytes and feeder cells (growth-inactivated fibroblast and epithelial cells), to evaluate thyroxine glucuronide (T4G) formation, a key metabolite in thyroid hormone metabolism and a critical endpoint for assessing liver-mediated thyroid disruption. The work focuses on quantifying interspecies differences in T4G formation following exposure to nuclear receptor reference agonists (NR-RFs), while also establishing historical control data (HCD), assay acceptability criteria, a suitable positive control, and interpretation criteria.